Cite
HARVARD Citation
Cahn, P. et al. (2020). Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies. Journal of infection and public health. 13 (2), pp. 349-350. [Online].